| Literature DB >> 28806854 |
Luke A Wiley1,2, Kristin R Anfinson1,2, Cathryn M Cranston1,2, Emily E Kaalberg1,2, Malia M Collins1,2, Robert F Mullins1,2, Edwin M Stone1,2, Budd A Tucker1,2.
Abstract
This unit describes protocols for the generation of clinical-grade patient-specific induced pluripotent stem cell (iPSC)-derived retinal cells from patients with inherited retinal degenerative blindness. Specifically, we describe how, using xeno-free reagents in an ISO class 5 environment, one can isolate and culture dermal fibroblasts, generate iPSCs, and derive autologous retinal cells via 3-D differentiation. The universal methods described herein for the isolation of dermal fibroblasts and generation of iPSCs can be employed regardless of disease, tissue, or cell type of interest. © 2017 by John Wiley & Sons, Inc.Entities:
Keywords: cGMP; current Good Manufacturing Practice; fibroblasts; induced pluripotent stem cells; photoreceptor precursor cells; retina; xeno-free
Mesh:
Year: 2017 PMID: 28806854 PMCID: PMC5609845 DOI: 10.1002/cpsc.30
Source DB: PubMed Journal: Curr Protoc Stem Cell Biol ISSN: 1938-8969